J.M. Llovet, R.K. Kelley, A. Villanueva, A.G. Singal, E. Pikarsky, S. Roayaie, R. Lencioni, K. Koike, J. Zucman-Rossi, R.S. Finn, Hepatocellular carcinoma. Nat. Rev. Dis. Primers. 7(1), 6 (2021)

Article  PubMed  Google Scholar 

G.P. Nagaraju, B. Dariya, P. Kasa, S. Peela, B.F. El-Rayes, Epigenetics in hepatocellular carcinoma. Semin Cancer Biol. 86(Pt 3), 622–632 (2022)

Article  PubMed  CAS  Google Scholar 

Y.T. Chan, C. Zhang, J. Wu, P. Lu, L. Xu, H. Yuan, Y. Feng, Z.S. Chen, N. Wang, Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Mol. Cancer. 23(1), 189 (2024)

Article  PubMed  PubMed Central  Google Scholar 

A. Forner, M. Reig, J. Bruix, Hepatocellular carcinoma. Lancet. 391(10127), 1301–1314 (2018)

Article  PubMed  Google Scholar 

F. Bray, M. Laversanne, H. Sung, J. Ferlay, R.L. Siegel, I. Soerjomataram, A. Jemal, Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74(3), 229–263 (2024)

Article  Google Scholar 

Y. Zhang, Y. Wang, J.-H. Guo, J. Lu, Current Trends in Hepatocellular Carcinoma Therapies in China. Dig. Disease Interventions. 8(3), 173–182 (2024)

Article  Google Scholar 

F. Jaber, G. Cholankeril, H.B. El-Serag, Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies. J. Can. Association Gastroenterol. 7(5), 331–345 (2024)

Article  Google Scholar 

J. Zheng, S. Wang, L. Xia, Z. Sun, K.M. Chan, R. Bernards, W. Qin, J. Chen, Q. Xia, H. Jin, Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal. Transduct. Target. Ther. 10(1), 35 (2025)

Article  PubMed  PubMed Central  Google Scholar 

S. Roayaie, G. Jibara, P. Tabrizian, J.W. Park, J. Yang, L. Yan, M. Schwartz, G. Han, F. Izzo, M. Chen et al., The role of hepatic resection in the treatment of hepatocellular cancer. Hepatol. (Baltimore Md). 62(2), 440–451 (2015)

Article  CAS  Google Scholar 

G. Cabibbo, M. Enea, M. Attanasio, J. Bruix, A. Craxì, C. Cammà, A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatol. (Baltimore Md). 51(4), 1274–1283 (2010)

Article  Google Scholar 

A. Vogel, A. Cervantes, I. Chau, B. Daniele, J.M. Llovet, T. Meyer, J.C. Nault, U. Neumann, J. Ricke, B. Sangro et al., Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals oncology: official J. Eur. Soc. Med. Oncol. 29(Suppl 4), iv238–iv255 (2018)

Article  CAS  Google Scholar 

W. Zhang, S. Tong, B. Hu, T. Wan, H. Tang, F. Zhao, T. Jiao, J. Li, Z. Zhang, J. Cai et al., Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial. J. Immunother. Cancer 2023, 11(9)

J.H. Choi, W.J. Chung, S.H. Bae, D.S. Song, M.J. Song, Y.S. Kim, H.J. Yim, Y.K. Jung, S.J. Suh, J.Y. Park et al., Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. Cancer Chemother. Pharmacol. 82(3), 469–478 (2018)

Article  PubMed  CAS  Google Scholar 

M. Jiang, C. Chen, Y. Hu, G. Lin, H. Li, Locoregional therapy combined with targeted therapy and immunotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. Sci. Rep. 15(1), 39494 (2025)

Article  PubMed  PubMed Central  CAS  Google Scholar 

Q.J. Li, M.K. He, H.W. Chen, W.Q. Fang, Y.M. Zhou, L. Xu, W. Wei, Y.J. Zhang, Y. Guo, R.P. Guo et al., Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial. J. Clin. oncology: official J. Am. Soc. Clin. Oncol. 40(2), 150–160 (2022)

Article  CAS  Google Scholar 

M. He, Q. Li, R. Zou, J. Shen, W. Fang, G. Tan, Y. Zhou, X. Wu, L. Xu, W. Wei et al., Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial. JAMA Oncol. 5(7), 953–960 (2019)

Article  PubMed  PubMed Central  Google Scholar 

H. Iwamoto, S. Shimose, T. Shirono, T. Niizeki, T. Kawaguchi, Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity. Clin. Mol. Hepatol. 29(3), 593–604 (2023)

Article  PubMed  PubMed Central  Google Scholar 

T.Q. Zhang, Z.J. Geng, M.X. Zuo, J.B. Li, J.H. Huang, Z.L. Huang, P.H. Wu, Y.K. Gu, Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study. Signal. Transduct. Target. Ther. 8(1), 413 (2023)

Article  PubMed  PubMed Central  CAS  Google Scholar 

Y. Yuan, W. He, Z. Yang, J. Qiu, Z. Huang, Y. Shi, Z. Lin, Y. Zheng, M. Chen, W.Y. Lau et al., TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study. Int. J. Surg. (London England). 109(5), 1222–1230 (2023)

Article  Google Scholar 

C. Zhang, Y. Xu, L. Cai, S. Zhou, J. Feng, S. Fu, W. Wang, W. Liang, C. Li, W. Guo et al., Efficacy of combined TAE, HAIC, targeted, and immunotherapy in unresectable HCC: a multicenter propensity score matching study. Sci. Rep. 15(1), 21184 (2025)

Article  PubMed  PubMed Central  Google Scholar 

N. Lyu, Y. Kong, L. Mu, Y. Lin, J. Li, Y. Liu, Z. Zhang, L. Zheng, H. Deng, S. Li et al., Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma. J. Hepatol. 69(1), 60–69 (2018)

Article  PubMed  Google Scholar 

J. Chen, R. Jin, J. Zhao, J. Liu, H. Ying, H. Yan, S. Zhou, Y. Liang, D. Huang, X. Liang et al., Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma. Cancer Lett. 367(1), 1–11 (2015)

Article  PubMed  CAS  Google Scholar 

C. Wu, Z. Fu, L. Pan, J. Li, Y. Zhou, R. Sun, Y. Gou, Y. Zhao, Z. Wang, Y. Qiu et al., Efficacy and Safety of Hepatic Artery Infusion Chemotherapy Combined with Donafenib and Camrelizumab in the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Retrospective, Single-Arm Study. J. hepatocellular carcinoma. 12, 1353–1367 (2025)

Article  CAS  Google Scholar 

H. Li, T. Si, R. Li, X. Xie, Y. Liu, L. Fu, Y. Bai, J. Yao, X. Zhang, M. Yang et al., Hepatic arterial infusion chemotherapy with serplulimab and the bevacizumab biosimilar HLX04 for advanced hepatocellular carcinoma: a prospective, observational phase II clinical trial. Cancers. 17(19), (2025)

EASL-EASD-EASO Clinical, Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol. 81(3), 492–542 (2024)

Article  Google Scholar 

X. Yang, C. Yang, S. Zhang, H. Geng, A.X. Zhu, R. Bernards, W. Qin, J. Fan, C. Wang, Q. Gao, Precision treatment in advanced hepatocellular carcinoma. Cancer cell. 42(2), 180–197 (2024)

Article  PubMed  CAS  Google Scholar 

F. Safri, R. Nguyen, S. Zerehpooshnesfchi, J. George, L. Qiao, Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications. Cancer Gene Ther. 31(8), 1105–1112 (2024)

Article  PubMed  PubMed Central  CAS  Google Scholar 

A. Vogel, T. Meyer, G. Sapisochin, R. Salem, A. Saborowski, Hepatocellular carcinoma. Lancet (London England). 400(10360), 1345–1362 (2022)

Article  PubMed  CAS  Google Scholar 

O. Prior, C. Macarro, V. Navarro, C. Monreal, M. Ligero, A. Garcia-Ruiz, G. Serna, S. Simonetti, I. Braña, M. Vieito et al., Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer. Radiol. Artif. Intell. 6(2), e230118 (2024)

Article  PubMed  PubMed Central  Google Scholar 

Y. Gao, Z. Li, X. Zhai, G. Zhang, L. Zhang, T. Huang, L. Han, J. Wang, R. Yan, Y. Li et al., MRI-based habitat radiomics combined with vision transformer for identifying vulnerable intracranial atherosclerotic plaques and predicting stroke events: a multicenter, retrospective study. EClinicalMedicine. 82, 103186 (2025)

Article  PubMed  PubMed Central  Google Scholar 

Y. Wu, W. Zhang, X. Liang, P. Zhang, M. Zhang, Y. Jiang, Y. Cui, Y. Chen, W. Zhou, Q. Liang et al., Habitat radiomics analysis for progression free survival and immune-related adverse reaction prediction in non-small cell lung cancer treated by immunotherapy. J. translational Med. 23(1), 393 (2025)

Article  CAS  Google Scholar 

Y. Zhang, J. Chen, C. Yang, Y. Dai, M. Zeng, Preoperative prediction of microvascular invasion in hepatocellular carcinoma using diffusion-weighted imaging-based habitat imaging. Eur. Radiol. 34(5), 3215–3225 (2024)

Article  PubMed  CAS  Google Scholar 

H.F. Liu, M. Wang, Y.J. Lu, Q. Wang, Y. Lu, F. Xing, W. Xing, CEMRI-Based Quantification of Intratumoral Heterogeneity for Predicting Aggressive Characteristics of Hepatocellular Carcinoma Using Habitat Analysis: Comparison and Combination of Deep Learning. Acad. Radiol. 31(6), 2346–2355 (2024)

Article